{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:57:16Z","timestamp":1770746236483,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s13730-021-00643-5","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T06:02:37Z","timestamp":1631512957000},"page":"141-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Successful treatment with denosumab for two cases with hypercalcemia due to vitamin D intoxication and associated acute kidney injury"],"prefix":"10.1007","volume":"11","author":[{"given":"Katharina","family":"Barth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Sedivy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0765-351X","authenticated-orcid":false,"given":"Christoph","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"12","key":"643_CR1","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1210\/jc.2011-1443","volume":"96","author":"T Araki","year":"2011","unstructured":"Araki T, Holick MF, Alfonso BD, et al. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. J Clin Endocrinol Metab. 2011;96(12):3603\u20138. https:\/\/doi.org\/10.1210\/jc.2011-1443.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"643_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.mayocp.2015.02.012","volume":"90","author":"DV Dudenkov","year":"2015","unstructured":"Dudenkov DV, Yawn BP, Oberhelman SS, et al. Changing incidence of serum 25-hydroxyvitamin D values above 50 ng\/mL: a 10-year population-based study. Mayo Clin Proc. 2015;90(5):577\u201386. https:\/\/doi.org\/10.1016\/j.mayocp.2015.02.012.","journal-title":"Mayo Clin Proc"},{"key":"643_CR3","unstructured":"Kolata G. Why are so many people popping vitamin D? The New York Times. https:\/\/www.nytimes.com\/2017\/04\/10\/health\/vitamin-d-deficiency-supplements.html. Published April 10, 2017. Accessed 20 Aug 2020."},{"issue":"1","key":"643_CR4","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","volume":"289","author":"AS Dusso","year":"2005","unstructured":"Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Ren Physiol. 2005;289(1):F8-28. https:\/\/doi.org\/10.1152\/ajprenal.00336.2004.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"643_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2265.1995.tb02916.x","volume":"43","author":"PL Selby","year":"1995","unstructured":"Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol. 1995;43(5):531\u20136. https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb02916.x.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"643_CR6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.abb.2010.10.012","volume":"505","author":"HF Deluca","year":"2011","unstructured":"Deluca HF, Prahl JM, Plum LA. 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. Arch Biochem Biophys. 2011;505(2):226\u201330. https:\/\/doi.org\/10.1016\/j.abb.2010.10.012.","journal-title":"Arch Biochem Biophys"},{"key":"643_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fendo.2018.00550","volume":"9","author":"E Marcinowska-Suchowierska","year":"2018","unstructured":"Marcinowska-Suchowierska E, Kupisz-Urba\u0144ska M, \u0141ukaszkiewicz J, P\u0142udowski P, Jones G. Vitamin D toxicity-a clinical perspective. Front Endocrinol. 2018;9:550. https:\/\/doi.org\/10.3389\/fendo.2018.00550.","journal-title":"Front Endocrinol"},{"issue":"11","key":"643_CR8","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1210\/jc.2005-0675","volume":"90","author":"TP Jacobs","year":"2005","unstructured":"Jacobs TP, Bilezikian JP. Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005;90(11):6316\u201322. https:\/\/doi.org\/10.1210\/jc.2005-0675.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"643_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1056\/NEJMoa1103864","volume":"365","author":"KP Schlingmann","year":"2011","unstructured":"Schlingmann KP, Kaufmann M, Weber S, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011;365(5):410\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1103864.","journal-title":"N Engl J Med"},{"issue":"3","key":"643_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1060028020953501","volume":"55","author":"S Palmer","year":"2021","unstructured":"Palmer S, Tillman F, Sharma P, et al. Safety of intravenous bisphosphonates for the treatment of hypercalcemia in patients with preexisting renal dysfunction. Ann Pharmacother. 2021;55(3):303\u201310. https:\/\/doi.org\/10.1177\/1060028020953501.","journal-title":"Ann Pharmacother"},{"issue":"11","key":"643_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5414\/CN108904","volume":"86","author":"M Wani","year":"2016","unstructured":"Wani M, Wani I, Banday K, Ashraf M. The other side of vitamin D therapy: a case series of acute kidney injury due to malpractice-related vitamin D intoxication. Clin Nephrol. 2016;86(11):236\u201341. https:\/\/doi.org\/10.5414\/CN108904.","journal-title":"Clin Nephrol"},{"issue":"1","key":"643_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13613-019-0606-8","volume":"9","author":"C Mousseaux","year":"2019","unstructured":"Mousseaux C, Dupont A, Rafat C, et al. Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients. Ann Intensive Care. 2019;9(1):133. https:\/\/doi.org\/10.1186\/s13613-019-0606-8.","journal-title":"Ann Intensive Care"},{"issue":"4","key":"643_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10735-016-9681-4","volume":"47","author":"J Sun","year":"2016","unstructured":"Sun J, Sun B, Wang W, et al. Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats. J Mol Histol. 2016;47(4):389\u201399. https:\/\/doi.org\/10.1007\/s10735-016-9681-4.","journal-title":"J Mol Histol"},{"issue":"21","key":"643_CR14","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.2217\/fon.15.232","volume":"11","author":"S Thosani","year":"2015","unstructured":"Thosani S, Hu MI. Denosumab: a new agent in the management of hypercalcemia of malignancy. Future Oncol. 2015;11(21):2865\u201371. https:\/\/doi.org\/10.2217\/fon.15.232.","journal-title":"Future Oncol"},{"issue":"12","key":"643_CR15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.7326\/0003-4819-156-12-201206190-00026","volume":"156","author":"A Bech","year":"2012","unstructured":"Bech A, de Boer H. Denosumab for tumor-induced hypercalcemia complicated by renal failure. Ann Intern Med. 2012;156(12):906\u20137. https:\/\/doi.org\/10.7326\/0003-4819-156-12-201206190-00026.","journal-title":"Ann Intern Med"},{"issue":"6","key":"643_CR16","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.clml.2014.07.005","volume":"14","author":"JD Cicci","year":"2014","unstructured":"Cicci JD, Buie L, Bates J, van Deventer H. Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction. Clin Lymphoma Myeloma Leuk. 2014;14(6):e207-211. https:\/\/doi.org\/10.1016\/j.clml.2014.07.005.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"643_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/ckj\/sfs116","volume":"5","author":"E de Beus","year":"2012","unstructured":"de Beus E, Boer WH. Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure. Clin Kidney J. 2012;5(6):566\u201371. https:\/\/doi.org\/10.1093\/ckj\/sfs116.","journal-title":"Clin Kidney J"},{"key":"643_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000505257","volume":"49","author":"E Seiringer","year":"2020","unstructured":"Seiringer E, Prischl FC, Teufel A, Wimmer L, Windpessl M, Wallner M. Acute kidney injury in a patient with multiple sclerosis. Blood Purif. 2020;49:232\u201353.","journal-title":"Blood Purif"},{"issue":"2","key":"643_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4103\/ijem.IJEM_678_18","volume":"23","author":"R Rajan","year":"2019","unstructured":"Rajan R, Cherian KE, Kapoor N, Paul TV. Denosumab as a bridge to surgery in a patient with severe hypercalcemia due to primary hyperparathyroidism in the setting of renal dysfunction. Indian J Endocrinol Metab. 2019;23(2):269\u201370. https:\/\/doi.org\/10.4103\/ijem.IJEM_678_18.","journal-title":"Indian J Endocrinol Metab"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00643-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-021-00643-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-021-00643-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T17:56:02Z","timestamp":1643824562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-021-00643-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s13730-021-00643-5","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"29 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from patients included in the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}